We have located links that may give you full text access.
First experience of the usage of a GORE CARDIOFORM Septal Occluder device for treatment of a significant residual commissural mitral regurgitation jet following a MitraClip procedure.
Catheterization and Cardiovascular Interventions 2018 September 2
The MitraClip (Abbott Vascular, Santa Clara, CA) procedure has emerged as a safe and effective treatment option for treatment of selected patients with severe mitral regurgitation (MR) who are at high risk for surgery. Effective reduction of MR is important to ensure an optimal clinical outcome. We present here the first case report of a significant commissural leak after a MitraClip procedure treated with a GORE CARDIOFORM Septal Occluder device (WL Gore & Associates, Flagstaff, AZ).
CASE REPORT: An 81-year-old male presented with symptomatic recurrent MR following a MitraClip procedure using two clips. After adding another clip, there was still a residual jet medially. We plugged the gap using 12-mm AMPLATZER Muscular VSD Occluder device (St. Jude Medical, Minneapolis, MN). MR was reduced but hemolysis occurred. We retrieved the VSD Occluder device to improve hemolysis, but the MR jet worsened to severe, so we placed a 30-mm GORE CARDIOFORM Septal Occluder device. The device was stable, the MR jet was reduced dramatically, and hemolysis was not observed. Materials of these devices are mesh fabric made from nitinol and polyester in a VSD Occluder device and expanded polytetrafluoroethylene in GORE CARDIOFORM Septal Occluder device. The difference between device materials affects flow pattern of residual jet and hemolysis. In conclusion, the patient's risk for hemolysis is potentially affected by the occluder or plug material. GORE CARDIOFORM is a feasible choice to reduce the risk of hemolysis in a selected patient.
CASE REPORT: An 81-year-old male presented with symptomatic recurrent MR following a MitraClip procedure using two clips. After adding another clip, there was still a residual jet medially. We plugged the gap using 12-mm AMPLATZER Muscular VSD Occluder device (St. Jude Medical, Minneapolis, MN). MR was reduced but hemolysis occurred. We retrieved the VSD Occluder device to improve hemolysis, but the MR jet worsened to severe, so we placed a 30-mm GORE CARDIOFORM Septal Occluder device. The device was stable, the MR jet was reduced dramatically, and hemolysis was not observed. Materials of these devices are mesh fabric made from nitinol and polyester in a VSD Occluder device and expanded polytetrafluoroethylene in GORE CARDIOFORM Septal Occluder device. The difference between device materials affects flow pattern of residual jet and hemolysis. In conclusion, the patient's risk for hemolysis is potentially affected by the occluder or plug material. GORE CARDIOFORM is a feasible choice to reduce the risk of hemolysis in a selected patient.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app